Imaging of lesions in a murine rheumatoid arthritis model with a humanized anti-interleukin-6 receptor antibody

Annals of Nuclear Medicine

Volumn 19, Issue 4, 2005, Pages 261-266

  Sugimoto, Kanji ^a   Nishimoto, Norihiro ^b   Kishimoto, Tadamitsu ^a   Yoshizaki, Kazuyuki ^b   Nishimura, Tsunehiko ^c  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

HYNIC; Interleukin 6; Rheumatoid arthritis; Scintigraphic imaging; Technetium 99m

Indexed keywords

CHELATING AGENT; HYDORAZINONICOTINAMIDE; INTERLEUKIN 6 ANTIBODY; INTERLEUKIN 6 RECEPTOR; RECEPTOR ANTIBODY; TECHNETIUM 99M; TECHNETIUM COMPLEX; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; WHOLE BODY SCINTISCANNING;

EID: 23344433680     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02984617     Document Type: Article

References (16)

1. Arend WP, Dayer JM. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum 1995; 38 (2): 151-160.
2. Hirano T, Taga T, Nakano N, Yasukawa K, Kashiwamura S, Shimizu K, et al. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci USA 1985; 82: 5490-5494.
3. Takagi Y, Wong GG, Clark SC, Burakoff SJ, Herrmann SH. B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. J Immunol 1988; 140: 508-512.
4. Asano S, Okano A, Ozawa K, Nakahata T, Ishibashi T, Koike K, et al. In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets. Blood 1990; 75: 1602-1605.
5. Kishimoto T. The biology of interleukin-6. Blood 1989; 74: 1-10.
6. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci USA 1993; 90: 11924-11928.
7. Houssiau FA, Devogelaer JP, van Damme J, de Deuxchaisnes CN, van Snick J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 1988; 31: 784-788.
8. Swaak AJ, van Rooyen A, Nieuwenhuis E, Aarden LA. Interleukin-6 (IL-6) in synovial fluid and serum of patients with rheumatic diseases. Scand J Rheumatol 1988; 17: 469-474.
9. Sato K, Tsuchiya M, Saldanha J, Koishihara Y, Ohsugi Y, Kishimoto T, et al. Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth. Cancer Res 1993; 53 (4): 851-856.
10. Hagihara K, Nishimoto N, Yoshizaki K. A humanized anti-IL-6 receptor antibody (MRA) in RA therapy. Nippon Rinsho 2002; 60 (12): 2401-2407.
11. Yoshizaki K, Nishimoto N, Mihara M, Kishimoto T. Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody. Springer Semin Immunopathol 1998; 20: 247-259.
12. Nishimoto N, Kishimoto T, Yoshizaki K. Anti-interleukin 6 receptor antibody treatment in rheumatic disease. Ann Rheum Dis 2000; 59 Suppl 1: i21-27.
13. Abrams MJ, Juweid M, tenKate CI, Schwartz DA, Hauser MM, Gaul FE, et al. Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med 1990; 31: 2022-2028.
14. Larsen SK, Solomon HF, Caldwell G, Abrams MJ. [99m-Tc]tricine: a useful precursor complex for the radiolabeling of hydrazinonicotinate protein conjugates. Bioconjugate Chem 1995; 6: 635-638.
15. Matsuno H, Sawai T, Nezuka T, Uzuki M, Tsuji H, Nishimoto N, et al. Treatment of rheumatoid synovitis with anti-reshaping human interleukin-6 receptor monoclonal antibody: use of rheumatoid arthritis tissue implants in the SCID mouse model. Arthritis Rheum 1998; 41 (11): 2014-2021.
16. Taga T, Kawanishi Y, Hardy RR, Hirano T, Kishimoto T. Receptors for B cell stimulatory factor 2: Quantitation, specificity, distribution, and regulation of their expression. J Exp Med 1987; 166: 967-981.